Emergent CRO is a MedTech-focused clinical research organization supporting orthopedic, spine, and sports medicine innovators from first-in-human through post-market. We deliver senior-level oversight, agile execution, and transparent pricing. Acting as an extension of your team, we integrate seamlessly to design smarter studies, activate the right sites, and keep trials moving forward. We don’t just manage studies, we become true partners in your success. Built to Care. Built for MedTech!
EMD Serono
EMD Serono, the healthcare business sector of Merck KGaA, Darmstadt, Germany, in the US and Canada, is a science-led organization dedicated to making a meaningful difference in the lives of people affected by cancer. Our oncology research aims to leverage our synergistic portfolio to tackle challenging tumor types, as we work to illuminate a path to scientific breakthroughs to transform patient outcomes. Learn more at www.emdseronooncology.com | We are the healthcare business in the U.S.A. & Canada for Merck KGaA, Darmstadt, Germany, a vibrant science and technology company. Science is at the heart of everything we do. It drives the discoveries we make and the technologies we create. The passion of our curious minds makes a positive difference to millions of people’s lives every day. In Healthcare, we discover unique ways to treat the most challenging diseases, such as multiple sclerosis and cancer. Our Life Science experts empower scientists by developing tools and solutions that help deliver breakthroughs more quickly. And in Electronics, we develop science that sits inside technologies and changes the way we access, store, process, and display information. Everything we do is fueled by a belief in science and technology as a force for good. A belief that has driven our work since 1668 and will continue to inspire us to find more joyful and sustainable ways to live. We are curious minds dedicated to human progress. | In Healthcare, we are at the forefront of developing pioneering therapies – boldly aiming to meaningfully change the lives of patients, their families, and their caregivers. We are unlocking leaps in highly specialized fields with significant unmet medical needs. We leverage internal discoveries and external partnerships to serve patients who need it most across all continents. As one company, science is at the heart of everything we do. It drives the discoveries we make and the technologies we create. The passion of our curious minds makes a positive difference to millions of people’s lives every day. Life Science experts empower scientists by developing tools and solutions that help deliver breakthroughs more quickly. And in Electronics, we develop science that sits inside technologies and changes the way we access, store, process, and display information. Everything we do is fueled by a belief in science and technology as a force for good. A belief that has driven our work since 1668 and will continue to inspire us to find more joyful and sustainable ways to live. We are sparking discovery, elevating humanity. | We are the healthcare business in the U.S.A. & Canada for Merck KGaA, Darmstadt, Germany, a vibrant science and technology company. EMD Serono Aspires to create, improve and prolong lives — As One for Patients. Science is at the heart of everything we do. It drives the discoveries we make and the technologies we create. The passion of our curious minds makes a positive difference to millions of people’s lives every day. In Healthcare, we discover unique ways to treat the most challenging diseases, such as multiple sclerosis and cancer. Our Life Science experts empower scientists by developing tools and solutions that help deliver breakthroughs more quickly. And in Electronics, we develop science that sits inside technologies and changes the way we access, store, process, and display information. Everything we do is fueled by a belief in science and technology as a force for good. A belief that has driven our work since 1668 and will continue to inspire us to find more joyful and sustainable ways to live. We are curious minds dedicated to human progress.
Elsevier
As a global leader in information and analytics, we help researchers and healthcare professionals to advance science and improve health outcomes, striving to create a better future for everyone. We offer evidence-based information and advanced AI solutions to support the work of the research and healthcare communities worldwide. | A global leader in advanced information and decision support, Elsevier helps to advance science and healthcare, to advance human progress. We do this by facilitating insights and critical decision-making with innovative solutions based on trusted, evidence-based content and advanced AI-enabled digital technologies. | Elsevier Health applies innovation, facilitates insights, and helps drive more informed decision-making for students, clinicians, leaders, educators and policymakers, across healthcare systems globally. We support health providers by supplying accessible, trusted evidence-based information to take on the infodemic; preparing more future health professionals; improving patient outcomes; delivering truly inclusive healthcare; and supporting personalized and localized care experiences. Together, we aim to empower healthcare professionals to provide optimal care that improves outcomes for all patients. | A global leader in advanced information and decision support, Elsevier helps to advance science and healthcare, to advance human progress. We do this by facilitating insights and critical decision-making with innovative solutions based on trusted, evidence-based content and advanced AI-enabled digital technologies. We have supported the work of our research and healthcare communities for more than 140 years. Our 9,700 employees around the world, including 2,300 technologists, are dedicated to supporting researchers, librarians, academic leaders, funders, governments, R&D-intensive companies, doctors, nurses, future healthcare professionals and educators in their critical work. Our 3,000 scientific journals and iconic reference books include the foremost titles in their fields, including Cell Press, The Lancet and Gray’s Anatomy. Together with the Elsevier Foundation, we work in partnership with the communities we serve to advance inclusion in science, research and healthcare in developing countries and around the world. Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. For more information on our work, digital solutions and content, visit www.elsevier.com. | For more than 140 years, Elsevier has helped advance science and human progress. We’ve evolved to a global leader in seamlessly integrating trusted content, technology and scientific expertise to support research and development. Discover, innovate and develop with confidence supported by a portfolio of connected, configurable solutions for R&D. | Elsevier, a global leader in information and analytics, helps researchers and healthcare professionals advance science and improve health outcomes for the benefit of society. Growing from our roots in publishing, we have supported the work of our research and health partners for more than 140 years. Powered by responsible AI, ClinicalKey AI is a clinical decision support solution that delivers relevant insights at the point of care sourced from trusted, evidence-based content.
Eli Lilly and Company
Lilly unites caring with discovery to create medicines that make life better for people around the world. We’ve been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 51 million people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world’s most significant health challenges, redefining diabetes care, treating obesity and curtailing its most devastating long-term effects, advancing the fight against Alzheimer’s disease, providing solutions to some of the most debilitating immune system disorders, and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we’re motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/newsroom. | Lilly unites caring with discovery to create medicines that improve lives for people around the world. We’ve been pioneering life-changing discoveries for nearly 150 years, and today, our medicines help more than 51 million people worldwide. We’re motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/newsroom or follow us on Facebook, Instagram, Twitter, and LinkedIn. | Lilly unites caring with discovery to create medicines that make life better for people around the world. We’ve been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 51 million people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world’s most significant health challenges, redefining diabetes care, treating obesity and curtailing its most devastating long-term effects, advancing the fight against Alzheimer’s disease, providing solutions to some of the most debilitating immune system disorders, and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we’re motivated by one thing: making life better for millions more people.
DNAnexus
DNAnexus: Accelerating the Future of Human Genetics and Precision Medicine The advancement of human genetics hinges on our ability to navigate and interpret vast, complex datasets. As research pushes the boundaries of discovery, from single-gene disorders to population-scale genomics, the challenges of data management, analysis, and collaboration have grown exponentially. DNAnexus is at the forefront of this evolution, providing a secure, scalable, and collaborative cloud-based platform designed to meet the unique needs of the global life sciences community. We are on a journey to democratize how researchers and clinicians work with clinico-genomic data, transforming it into actionable discoveries that improve patient outcomes. Unifying Complex, Multi-Modal Data at Scale DNAnexus leads the way in the management and analysis of multi-omics data to accelerate breakthroughs in precision medicine. Our Precision Health Data Cloud empowers life science organizations to seamlessly integrate complex genomic, transcriptomic, proteomic, clinical, and real-world datasets. This unified approach provides a holistic view of human biology, enabling researchers to uncover novel insights into disease mechanisms, identify new therapeutic targets, and power the next wave of drug discovery and development. The platform is built to handle data at scale, providing the robust foundation necessary for everything from rare disease analysis to large-scale population health studies. Fostering Secure Collaboration and Innovation Scientific progress is a collaborative endeavor. The DNAnexus platform provides a secure and collaborative environment where data can be combined and analyzed, fostering innovation without compromising on security or compliance. We enable this through solutions like Trusted Research Environments (TREs), which provide regulatory-grade spaces for dynamic collaboration and efficient, compliant submissions. Our unwavering commitment to the highest security standards ensures that sensitive data, privacy, and intellectual property are protected, allowing your teams to focus on what matters most: accelerating scientific discovery. Harnessing AI-Powered Analytics for Actionable Insights Built upon this foundation of integrated data and security, DNAnexus offers robust, AI-driven analytics to unlock the full potential of your research. By leveraging advanced AI and machine learning tools, our platform helps you move beyond raw data to find meaningful patterns and actionable insights. This empowers your organization to speed the journey from research to patient impact, simplifying regulatory compliance and driving innovations that improve healthcare for all. Engage with DNAnexus at ASHG 2025 to explore how our pioneering data analysis and management solutions can empower your research and help translate genetic discoveries into the future of precision health.
DIMA Biotechnology LLC
DIMA Biotechnology LLC accelerates cancer research through innovative membrane protein and monoclonal antibody discovery platforms. We specialize in producing full length, hard-to-express targets such as GPCRs, ion channels, and transporters et al. All our proteins are overexpressed in HEK293 cells to ensure high quality expression with correct PTMS. Our proprietary platforms include: – Synthetic Nanodisc, PeptiNanodisc, and Detergent-based systems: providing pure full length transmembrane proteins purified by affinity chromatography. – VLP (Virus Like Particles), MNP (Membrane Nano Particles), and Exosome-based systems—which present proteins in their native context but are not purified proteins. We offer over 500 Nanodisc products, with 300+ available in stock for next day delivery covering many GPCR and channel proteins. In antibody discovery, we provide both single B cell–derived rabbit mAbs and Nanobody development. We offer 5,000+ prevalidated recombinant mAb sequences targeting 500+ cancer relevant proteins, which are ready for out-licensing and testing. Additional IgG candidates can be screened within six weeks using proprietary B cell libraries. Our mammalian cell display platform supports antibody engineering services including humanization, affinity maturation, and functional screening. DIMA delivers integrated solutions from membrane protein production to antibody optimization to advance cancer research and therapeutic development.
Diamond Hoof Care
At Diamond Hoof Care, we understand the challenges of keeping your herd healthy and productive. That is why we deliver innovative, science-backed hoof care solutions that work. Our products, including Hoof-fit Gel, Repiderma, Hoof Sol Spray, and Hoof Sol Bath, simplify hoof care, reduce lameness, and improve herd performance. We go beyond products by offering practical advice, on-farm protocols, and hands-on support for farmers, veterinarians, and hoof trimmers. With over a decade of experience, we help clients boost animal welfare, save time, and achieve measurable results. Diamond Hoof Care is your partner in success.
Demeter Veterinary Services
Demeter remains a leader in swine health by proposing innovative solutions while prioritizing animal health and collaborating with producers to improve their profitability. A member of Swine Veterinary Partners, Demeter is part of a dynamic group of veterinarians, agronomists and nutritionists working together for industry sustainability.